CENTRE LEON BERARD ( Site 0305)

Lyon Cedex08, Auvergne-Rhône-Alpes 69373

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). — Running, not enrolling